Bita Arabshahi Robert A Silverman Olcay Y Jones Lisa G Rider
10.1016/j.jpeds.2011.11.057
J Pediatr
2012 Mar;160(3):520-2.
author_manuscript
https://pubmed.ncbi.nlm.nih.gov/22244459/
Anti-Inflammatory Agents / administration & dosage Antioxidants / administration & dosage Calcinosis / complications Chelating Agents / administration & dosage Dermatomyositis / drug therapy Immunoconjugates / administration & dosage Immunosuppressive Agents / administration & dosage Skin Ulcer / complications Thiosulfates / administration & dosage
Anti-Inflammatory Agents / administration & dosage Antioxidants / administration & dosage Calcinosis / complications Chelating Agents / administration & dosage Dermatomyositis / drug therapy Immunoconjugates / administration & dosage Immunosuppressive Agents / administration & dosage Skin Ulcer / complications Thiosulfates / administration & dosage Case Reports Research Support, N.I.H., Intramural Research Support, U.S. Gov't, Non-P.H.S. Abatacept Adolescent Dermatomyositis / complications Dermatomyositis / pathology Drug Therapy, Combination Female Humans Anti-Inflammatory Agents Antioxidants Chelating Agents Immunoconjugates Immunosuppressive Agents Thiosulfates Abatacept sodium thiosulfate
PMC3306811
22244459
Abatacept and sodium thiosulfate for treatment of recalcitrant juvenile dermatomyositis complicated by ulceration and calcinosis
2012